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Introduction: T-cell acute lymphoblastic leukemia (T-ALL) is a genetically 
heterogeneous cancer. Several driver oncogenes, including the TLX1 transcription 
factor, have been identified as early events that cooperate with other genetic 
aberrations towards full leukemogenesis. Recently, we established the TLX1 regulome 
and enhancer landscape for protein coding genes. An unanticipated downregulation 
of NOTCH1 and its target genes was observed explaining delayed leukemia formation 
in a TLX1 transgenic mouse model (Durinck et al., Leukemia, 2015). In this study, we 
expanded the dissection of the TLX1 regulome towards long non-coding RNAs 
(lncRNAs).  
Experimental procedures: We performed polyA and total RNA-sequencing following 
TLX1 knockdown in the ALL-SIL cell line and for a primary cohort of 64 T-ALLs, 
including 5 TLX1+ and 12 TLX3+ cases and also made use of our previously 
established TLX1 and H3K27ac ChIPseq data for further data mining. 
Results: We observed a strong association of TLX1 bound enhancers and expression 
of lncRNAs from these enhancer sites. We observed an unanticipated down regulation 
of the majority of TLX1 controlled lncRNAs while TLX1 mainly acts as a repressor of 
protein coding genes. To further investigate this unexplained relationship for TLX1 
controlled lncRNA and protein coding gene expression, we are performing LNA-
mediated lncRNA knockdown in combination with 4C-sequencing in order to explore 
the topological regulatory interactions between TLX1 regulated lncRNAs and their 
presumed cis-regulatory target genes. 
Conclusion: In conclusion, we established a comprehensive delineation of the TLX1 
controlled regulome and provide the first evidence for a previously unestablished role 
of (enhancer) lncRNAs in the TLX1 epigenetic regulatory network. 
 
